Literature DB >> 18790451

Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.

Jacob M Rowe1.   

Abstract

The graft-versus-leukaemia effect is one of the most important biological effects to influence outcome in patients with acute leukaemia. The recognition of this modality over the past three decades has led to far-reaching changes in the concept and conduct of allogeneic transplantation in acute myeloid leukaemia, and in the infusion of donor lymphocytes as a therapeutic modality. Despite these conceptual advances, there is a considerable need for more structured prospective studies to optimally define the role of reduced-intensity transplantation in both acute myeloid and acute lymphoblastic leukaemia.

Entities:  

Mesh:

Year:  2008        PMID: 18790451     DOI: 10.1016/j.beha.2008.07.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  6 in total

1.  Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years.

Authors:  J J Cornelissen; J Versluis; J R Passweg; W L J van Putten; M G Manz; J Maertens; H B Beverloo; P J M Valk; M van Marwijk Kooy; P W Wijermans; M R Schaafsma; B J Biemond; M-C Vekemans; D A Breems; L F Verdonck; M F Fey; M Jongen-Lavrencic; J J W M Janssen; G Huls; J Kuball; T Pabst; C Graux; H C Schouten; A Gratwohl; E Vellenga; G Ossenkoppele; B Löwenberg
Journal:  Leukemia       Date:  2014-11-27       Impact factor: 11.528

2.  Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.

Authors:  Ga-Young Song; TaeHyung Kim; Seo-Yeon Ahn; Sung-Hoon Jung; Mihee Kim; Deok-Hwan Yang; Je-Jung Lee; Seung Hyun Choi; Mi Yeon Kim; Chul Won Jung; Jun-Ho Jang; Hee Je Kim; Joon Ho Moon; Sang Kyun Sohn; Jong-Ho Won; Seong-Kyu Park; Sung-Hyun Kim; Zhaolei Zhang; Jae-Sook Ahn; Hyeoung-Joon Kim; Dennis Dong Hwan Kim
Journal:  Bone Marrow Transplant       Date:  2022-09-23       Impact factor: 5.174

3.  Immunomodulatory effects of vitamin D: implications for GVHD.

Authors:  J Rosenblatt; A Bissonnette; R Ahmad; Z Wu; B Vasir; K Stevenson; C Zarwan; W Keefe; B Glotzbecker; H Mills; R Joyce; J D Levine; D Tzachanis; V Boussiotis; D Kufe; D Avigan
Journal:  Bone Marrow Transplant       Date:  2010-01-18       Impact factor: 5.483

4.  Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.

Authors:  Roland B Walter; Sarah A Buckley; John M Pagel; Brent L Wood; Barry E Storer; Brenda M Sandmaier; Min Fang; Boglarka Gyurkocza; Colleen Delaney; Jerald P Radich; Elihu H Estey; Frederick R Appelbaum
Journal:  Blood       Date:  2013-07-11       Impact factor: 22.113

5.  Checkpoint-blocked T cells checkmate AML.

Authors:  Kirsten M Williams
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

Review 6.  The Graft-Versus-Leukemia Effect in AML.

Authors:  Connor Sweeney; Paresh Vyas
Journal:  Front Oncol       Date:  2019-11-19       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.